Apollo Hospitals joins hands with IBM Watson for cancer treatment
Posted on 22nd May 2018 |
.jpg) |
Apollo Hospitals on Tuesday adopted IBM's cognitive computing platform Watson for Oncology and Genomics in 10 of its cancer care hospitals. These platforms will help physicians provide patients with personalised, evidence-based cancer care. |
|
|
|
|
|
|
|
|
Apollo Hospitals hits 34-month low
Posted on 17th August 2017 |
.jpg) |
Apollo Hospitals Enterprise has slipped 7% to Rs 1,069, its lowest level since October 23, 2014 on BSE, in an otherwise firm market. The National Pharmaceutical Pricing Authority (NPPA) on Wednesday fixed the price for primary knee replacement of titanium alloy at Rs 38,740 while the price for revision knee replacement of any material was pegged at Rs 62,770. |
|
|
Apollo Hospitals looks at acquisition in North and West
Posted on 16th August 2017 |
.jpg) |
Apollo Hospitals Enterprise Ltd (AHEL), India's largest healthcare provider by market value, is considering the acquisition of small hospitals in northern and western parts of India. The company, which has been pursuing plans for the rights issue of around Rs 750 crore, said that it would look at other modes of fund raising also if the approvals for the rights issue is not coming by in next six months. |
|
|
Apollo, RMS launch cell therapy for orthopaedic patients
Posted on 19th June 2017 |
.jpg) |
Apollo Hospitals has tied up with biotechnology firm Regenerative Medical Services (RMS) to launch cell therapy for bone and cartilage defects. The companies, however, did not share the financial details of the partnership. The two cell therapy products – Ossron and Chondron – will address the unmet clinical needs in the bone and cartilage treatments respectively, the companies said. As part of the pact, the treatment will be made available across all Apollo Hospitals within next six months. |
|
|
Apollo Hospitals seeks to prop up falling occupancy to boost growth
Posted on 7th June 2017 |
.jpg) |
Apollo Hospitals Enterprise (AHEL) is focusing on increasing its occupancy to improve growth, which declined in the financial year (FY) 2016-17. The hospital has set the target of achieving 65 per cent occupancy by the end of the current FY from the 47 per cent occupancy at present, said senior management of the company. AHEL had posted a 40.7 per cent fall in profit at Rs 48.16 crore in the fourth quarter of the FY17 as compared to Rs 81.31 crore for the same period of the previous FY on a standalone basis. |
|
|
Apollo Hospitals family to form trust
Posted on 28th March 2017 |
.jpg) |
Apollo Hospitals Group, India's one of the largest healthcare enterprises, is creating a trust as part of its plan to form a family constitution to ensure smooth succession of the management at a time when the promoter family is becoming larger. A preamble of the constitution was signed by all the family members earlier this year, said a senior member of the family. |
|
|
Apollo Hospitals to restructure retail pharmacy business
Posted on 25th March 2017 |
.jpg) |
Apollo Hospitals Enterprise Ltd (AHEL) is looking at restructuring its retail pharmacy business in order to bring down the foreign holding in retail below 51 per cent. The move is expected to help the company get FIPB aaproval for its pending Rs 750 crore rights issue. The decision comes as the Foreign Investment Promotion Board (FIPB) has been holding back its approval for the hospital chain to raise Rs 750 crore from foreign investors. The FIPB had passed on AHEL's proposal to raise Rs 750 crore through rights issue to the Cabinet Committee on Economic Affairs (CCEA) for its consideration in a the meeting held on February 21, according to a latest announcement. |
|
|
Apollo Hospitals shares dip after IHH sells 6% stake
Posted on 4th March 2017 |
.jpg) |
Share price of Apollo Hospitals declined by over five per cent on Friday after a report said that Malaysia-based sovereign fund Khazanah's arm Integrated Healthcare Holdings (IIH) sold six per cent stake in the company. IHH already have invested into hospital sector in India other than the stake in Apollo Hospitals. The stock price has come down almost 5.31 per cent to Rs 1,246 following the stake sales for $160 million in Apollo hospital. |
|
|
|
|
|
|
.jpg)
.jpg)
